About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3774840
cn2
Allelic
Composition
Atf2tm3Nicj/Atf2tm3Nicj
Tg(KRT14-cre)1Efu/?
Genetic
Background
involves: C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Atf2tm3Nicj mutation (0 available); any Atf2 mutation (89 available)
Tg(KRT14-cre)1Efu mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• the median appearance of skin papillomas after topical application of carcinogens is five to six weeks earlier than in littermate controls
• mice have significantly greater numbers of papillomas 20 weeks after carcinogen treatment with a mean of 7 compared to 3 in littermate controls

integument
• the percentage of proliferating epithelial cells after TPA administration is twice that of littermate controls
• reduced levels of active caspase 3 were observed in the skin of mice treated with carcinogens suggesting apoptosis levels might be lower
• mice develop a significantly thickened hyperdermis after three topical applications of TPA
• thickness is twice that of wild-type mice after TPA application
• the median appearance of skin papillomas after topical application of carcinogens is five to six weeks earlier than in littermate controls
• mice have significantly greater numbers of papillomas 20 weeks after carcinogen treatment with a mean of 7 compared to 3 in littermate controls


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory